Vodošek Hojs, N.; Bevc, S.; Ekart, R.; Piko, N.; Petreski, T.; Hojs, R.
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Pharmaceuticals 2021, 14, 561.
https://doi.org/10.3390/ph14060561
AMA Style
Vodošek Hojs N, Bevc S, Ekart R, Piko N, Petreski T, Hojs R.
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Pharmaceuticals. 2021; 14(6):561.
https://doi.org/10.3390/ph14060561
Chicago/Turabian Style
Vodošek Hojs, Nina, Sebastjan Bevc, Robert Ekart, Nejc Piko, Tadej Petreski, and Radovan Hojs.
2021. "Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease" Pharmaceuticals 14, no. 6: 561.
https://doi.org/10.3390/ph14060561
APA Style
Vodošek Hojs, N., Bevc, S., Ekart, R., Piko, N., Petreski, T., & Hojs, R.
(2021). Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Pharmaceuticals, 14(6), 561.
https://doi.org/10.3390/ph14060561